Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic neuron | 3 studies | 35% ± 10% | |
glutamatergic neuron | 3 studies | 42% ± 12% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 27% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 1128.57 | 2639 / 2642 | 100% | 24.15 | 705 / 705 |
prostate | 100% | 1050.33 | 244 / 245 | 100% | 21.57 | 502 / 502 |
adrenal gland | 96% | 934.08 | 247 / 258 | 97% | 17.17 | 224 / 230 |
breast | 100% | 1034.07 | 458 / 459 | 92% | 5.90 | 1027 / 1118 |
thymus | 100% | 817.82 | 650 / 653 | 91% | 12.97 | 550 / 605 |
kidney | 94% | 471.75 | 84 / 89 | 96% | 8.05 | 863 / 901 |
ovary | 100% | 1121.46 | 180 / 180 | 90% | 5.01 | 386 / 430 |
skin | 93% | 709.67 | 1676 / 1809 | 97% | 19.61 | 458 / 472 |
lung | 98% | 775.44 | 564 / 578 | 85% | 4.67 | 983 / 1155 |
intestine | 99% | 1151.07 | 959 / 966 | 76% | 3.85 | 400 / 527 |
bladder | 100% | 1121.81 | 21 / 21 | 73% | 3.54 | 366 / 504 |
uterus | 99% | 1457.35 | 169 / 170 | 71% | 3.78 | 327 / 459 |
stomach | 94% | 654.74 | 337 / 359 | 77% | 4.08 | 219 / 286 |
liver | 96% | 474.08 | 217 / 226 | 69% | 2.91 | 279 / 406 |
esophagus | 93% | 1166.62 | 1351 / 1445 | 70% | 3.65 | 128 / 183 |
pancreas | 59% | 182.51 | 192 / 328 | 92% | 6.54 | 164 / 178 |
adipose | 100% | 1205.11 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1717.22 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 948.83 | 241 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 19.45 | 79 / 80 |
heart | 96% | 880.62 | 830 / 861 | 0% | 0 | 0 / 0 |
muscle | 96% | 450.15 | 772 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 93% | 8.27 | 27 / 29 |
tonsil | 0% | 0 | 0 / 0 | 73% | 2.76 | 33 / 45 |
peripheral blood | 24% | 131.29 | 221 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006805 | Biological process | xenobiotic metabolic process |
GO_0006082 | Biological process | organic acid metabolic process |
GO_1903604 | Biological process | cytochrome metabolic process |
GO_0097267 | Biological process | omega-hydroxylase P450 pathway |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005737 | Cellular component | cytoplasm |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0102033 | Molecular function | long-chain fatty acid omega-hydroxylase activity |
GO_0004497 | Molecular function | monooxygenase activity |
GO_0005506 | Molecular function | iron ion binding |
GO_0052869 | Molecular function | arachidonic acid omega-hydroxylase activity |
GO_0008395 | Molecular function | steroid hydroxylase activity |
GO_0020037 | Molecular function | heme binding |
GO_0016712 | Molecular function | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen |
Gene name | CYP2U1 |
Protein name | Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Cytochrome P450 (EC 1.14.14.-) |
Synonyms | |
Description | FUNCTION: A cytochrome P450 monooxygenase involved in the metabolism of arachidonic acid and its conjugates . Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (CPR; NADPH-ferrihemoprotein reductase) . Acts as an omega and omega-1 hydroxylase for arachidonic acid and possibly for other long chain fatty acids. May modulate the arachidonic acid signaling pathway and play a role in other fatty acid signaling processes . May down-regulate the biological activities of N-arachidonoyl-serotonin, an endocannabinoid that has anti-nociceptive effects through inhibition of fatty acid amide hydrolase FAAH, TRPV1 receptor and T-type calcium channels. Catalyzes C-2 oxidation of the indole ring of N-arachidonoyl-serotonin forming a less active product 2-oxo-N-arachidonoyl-serotonin . . FUNCTION: Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. . |
Accessions | ENST00000332884.11 [Q7Z449-1] Q7Z449 ENST00000508453.1 E9PGH5 |